Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 01st Jun 2015 09:48

Lamprell: Citi reiterates neutral recommendation and raises target to 155p.British Land: JP Morgan ups target to 970p from 950p and stays at overweight.Derwent London: JP Morgan raises target to 3,900p from 3,800p but keeps at overweight.Great Portland Estates: JP Morgan lifts target to 920p from 910p and stays at overweight.Big Yellow Group: JP Morgan raises target to 780p from 715p and keeps at overweight.Elementis: JP Morgan keeps at overweight but shaves target to 313p from 320p.Workspace: JP Morgan ups target to 980p from 920p but stays at overweight.Synthomer: JP Morgan lifts target to 280p from 215p and keeps at neutral.Shaftesbury: JP Morgan raises target to 980p from 900p and stays at overweight.Land Securities: JP Morgan improves target to 1,600p from 1,550p and keeps at overweight.DCC: Jefferies raises target to 5,900p from 4,500p and keeps at buy.Tate&Lyle: Jefferies improves target to 650p from 605p but stays at hold. UBS shaves target to 575p from 590p and keeps at neutral.AstraZeneca: Jefferies remains at buy. UBS stays at buy and keeps 5,550p target.Homeserve: UBS raises target to 420p from 385p but downgrades to neutral from buy.Telecity Group: UBS ups target to 1,145p from 960p and stays at neutral.KAZ Minerals: UBS stays at neutral with 230p target.TUI: Nomura ups target to 1,920p from 1,870p and stays at buy.Thomas Cook: Nomura keeps target at 135p and stays a neutral.Qinetiq: Berenberg raises target to 320p from 205p and stays at hold.Cairn Energy: RBC ups to outperform from sector perform and raises target to 250p from 220p.

Related Shares

More News
Today 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Today 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.